Microneedles offer drug delivery without the pain
This article was originally published in Clinica
Executive Summary
A skin patch containing hundreds of tiny needles which are much thinner than a human hair could offer diabetics a pain-free way to take insulin. The technology, which is being developed in the US, could be used to develop an intelligent device which can sense when the patient's blood sugar level is too high and then automatically deliver appropriate doses of the drug.
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.